Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 3
2005 3
2006 1
2007 3
2008 4
2009 1
2010 4
2011 5
2012 6
2013 3
2014 3
2015 3
2016 2
2017 3
2018 2
2019 6
2020 5
2021 7
2022 5
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension.
Díaz Del Campo LS, García-Redondo AB, Rodríguez C, Zaragoza C, Duro-Sánchez S, Palmas F, de Benito-Bueno A, Socuéllamos PG, Peraza DA, Rodrigues-Díez R, Valenzuela C, Dalli J, Salaices M, Briones AM. Díaz Del Campo LS, et al. Among authors: valenzuela c. Hypertension. 2023 Jan;80(1):84-96. doi: 10.1161/HYPERTENSIONAHA.122.19448. Epub 2022 Nov 7. Hypertension. 2023. PMID: 36337053 Free article.
KV1.5-KVβ1.3 Recycling Is PKC-Dependent.
Macias A, de la Cruz A, Peraza DA, Benito-Bueno A, Gonzalez T, Valenzuela C. Macias A, et al. Among authors: valenzuela c. Int J Mol Sci. 2021 Jan 29;22(3):1336. doi: 10.3390/ijms22031336. Int J Mol Sci. 2021. PMID: 33572906 Free PMC article.
Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular function.
Vera-Zambrano A, Baena-Nuevo M, Rinné S, Villegas-Esguevillas M, Barreira B, Telli G, de Benito-Bueno A, Blázquez JA, Climent B, Pérez-Vizcaino F, Valenzuela C, Decher N, Gonzalez T, Cogolludo A. Vera-Zambrano A, et al. Among authors: valenzuela c. Pharmacol Res. 2023 Mar;189:106684. doi: 10.1016/j.phrs.2023.106684. Epub 2023 Feb 3. Pharmacol Res. 2023. PMID: 36740150 Free article.
NeuroEPO plus (NeuralCIM®) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial.
Sosa S, Bringas G, Urrutia N, Peñalver AI, López D, González E, Fernández A, Hernández ZM, Viña A, Peña Y, Batista JF, Valenzuela C, León K, Crombet T, Rodríguez T, Pérez L; ATHENEA Investigators. Sosa S, et al. Among authors: valenzuela c. Alzheimers Res Ther. 2023 Dec 13;15(1):215. doi: 10.1186/s13195-023-01356-w. Alzheimers Res Ther. 2023. PMID: 38093366 Free PMC article. Clinical Trial.
The unconventional biogenesis of Kv7.1-KCNE1 complexes.
Oliveras A, Serrano-Novillo C, Moreno C, de la Cruz A, Valenzuela C, Soeller C, Comes N, Felipe A. Oliveras A, et al. Among authors: valenzuela c. Sci Adv. 2020 Apr 1;6(14):eaay4472. doi: 10.1126/sciadv.aay4472. eCollection 2020 Apr. Sci Adv. 2020. PMID: 32270035 Free PMC article.
Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction.
Paz-García M, Povo-Retana A, Jaén RI, Prieto P, Peraza DA, Zaragoza C, Hernandez-Jimenez M, Pineiro D, Regadera J, García-Bermejo ML, Rodríguez-Serrano EM, Sánchez-García S, Moro MA, Lizasoaín I, Delgado C, Valenzuela C, Boscá L. Paz-García M, et al. Among authors: valenzuela c. Biomed Pharmacother. 2023 Feb;158:114214. doi: 10.1016/j.biopha.2023.114214. Epub 2023 Jan 4. Biomed Pharmacother. 2023. PMID: 36916435 Free article.
Pharmacological Approaches for the Modulation of the Potassium Channel KV4.x and KChIPs.
Cercós P, Peraza DA, Benito-Bueno A, Socuéllamos PG, Aziz-Nignan A, Arrechaga-Estévez D, Beato E, Peña-Acevedo E, Albert A, González-Vera JA, Rodríguez Y, Martín-Martínez M, Valenzuela C, Gutiérrez-Rodríguez M. Cercós P, et al. Among authors: valenzuela c. Int J Mol Sci. 2021 Jan 31;22(3):1419. doi: 10.3390/ijms22031419. Int J Mol Sci. 2021. PMID: 33572566 Free PMC article. Review.
Pharmacology of cardiac potassium channels.
Tamargo J, Caballero R, Gómez R, Valenzuela C, Delpón E. Tamargo J, et al. Among authors: valenzuela c. Cardiovasc Res. 2004 Apr 1;62(1):9-33. doi: 10.1016/j.cardiores.2003.12.026. Cardiovasc Res. 2004. PMID: 15023549 Review.
74 results